Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janossy, G. Articles by Glencross, D. K. Search for Related Content PubMed PubMed Citation Articles by Janossy, G. Articles by Glencross, D. K.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2002, p. 1085-1094, Vol. 9, No. 5
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.5.1085-1094.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Affordable CD4⁺-T-Cell Counting by Flow Cytometry: CD45 Gating for Volumetric Analysis

George Janossy,^1* Ilesh V. Jani,¹ Nicholas J. Bradley,¹ Arsene Bikoue,¹ Tim Pitfield,¹ and Debbie K. Glencross²

HIV Immunology, Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, London, United Kingdom,¹ Department of Molecular Medicine and Hematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa²

Received 14 January 2002/ Returned for modification 19 March 2002/ Accepted 22 April 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
The flow cytometers that are currently supported by industry provide accurate CD4⁺-T-cell counts for monitoring human immunodeficiency virus disease but remain unaffordable for routine service work under resource-poor conditions. We therefore combined volumetric flow cytometry (measuring absolute lymphocyte counts in unit volumes of blood) and simpler protocols with generic monoclonal antibodies (MAbs) to increase cost efficiency. Volumetric absolute counts were generated using CD45/CD4 and CD45/CD8 MAb combinations in two parallel tubes. The percentage values for the various subsets were also determined within the leukocyte and lymphocyte populations utilizing a fully automated protocol. The levels of agreement between the newly developed method and the present industry standards, including both volumetric and bead-based systems using a full MAb panel for subset analysis, were tested by Bland-Altman analyses. The limits of agreement for CD4 counts generated by the volumetric methods using either CD45/CD4 (in a single tube) or the full Trio MAb panel (in three tubes) on the CytoronAbsolute flow cytometer were between -29 and +46 cells/mm³ with very little bias for CD4 counts (in favor of the Trio method: +8 CD4⁺ lymphocytes/mm³; 0.38% of lymphocytes). The limits of agreement for absolute CD4 counts yielded by the volumetric CD45/CD4 method and the bead-based method were between -118 and +98 cells/mm³, again with a negligible bias (-10 CD4⁺ lymphocytes/mm³). In the volumetric method using CD45/CD8, the strongly CD8⁺ cells were gated and the levels of agreement with the full Trio showed a minor bias (in favor of the Trio; +40 CD8⁺ cells/mm³; 5.2% of lymphocytes) without a significant influence on CD4/CD8 ratios. One trained flow cytometrist was able to process 300 to 400 stained tubes per day. This workload extrapolates to a throughput of >30,000 samples per year if both CD45/CD4 and CD45/CD8 stainings are performed for each patient or a throughput of >60,000 samples if only CD45/CD4 counts are tested in a single tube. Thus, on the basis of the high efficiency and excellent agreement with the present industry standards, volumetric flow cytometers with automated gating protocols and autobiosamplers, complemented by generic CD45, CD4, and CD8 MAbs used in two-color immunofluorescence, represent the most suitable arrangements for large regional laboratories in resource-poor settings.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Dedicated flow cytometers are designed to enumerate the absolute numbers and percentages of lymphocyte populations, such as subsets of T cells, B cells, and NK cells. In the clinical service for monitoring human immunodeficiency virus (HIV) disease, the primary aim is to deliver absolute CD4⁺-T-cell counts, and this is achieved with a remarkably high level of precision (9, 24, 26, 29, 30). Nevertheless, the various cytometric systems differ in complexity (9). It has recently been documented that routine CD4-T-cell enumeration can be simplified without compromising quality (13, 18, 32), leading to cost-effective services for patients who receive generic antiretroviral drugs in resource-poor settings (Fig. 1).

View larger version (41K): [in this window] [in a new window]

FIG. 1. Recent events leading to affordable CD4-T-cell enumeration by flow cytometry. NIBSC, National Institute for Biological Standards and Control; NEQAS, UK National External Quality Assessment Service, Sheffield, United Kingdom; QASI, Quality Assessment & Standardization for Immunology, Ottawa, Canada.

Among the flow cytometers, dedicated instruments operating as "single platforms" are preferred due to their convenience and accuracy (9, 24, 26, 29, 30). These single platforms are based either on a volumetric principle by counting CD4⁺ T cells in a unit volume of blood (24, 26) or on the concept of adding known numbers of fluorospheres, or "microbeads," to each sample (29, 30). These beads are, however, precision products that can increase running costs. Consequently, services handling large numbers of samples had to revert to "double platforms" operating a panleucogating strategy with CD45 monoclonal antibody (MAb) to secure a much less expensive but still accurate mode of operation (13, 19). Indeed, the CD45-based gating, an example of the "heterogeneous" gating strategy, is a more reliable protocol (12, 13, 20, 25) when used with autogating in aging samples (4, 13, 25) than the conventional gating strategies that utilize morphological scatter gates (27, 31).

Despite the present interest in improving the efficacy of routine flow cytometry (Fig. 1), the performance of volumetric flow cytometric systems (10, 18, 24) operating with CD45-based gating (4, 13) and generic MAbs has not yet been assessed. We have therefore investigated the following topics: (i) the agreement between the results of CD45/CD4 staining using simple panleucogating (13) on volumetric single platforms and those obtained on the full volumetric (24) and bead-based (30) systems during CD4⁺-T-cell enumeration, including both absolute counts and CD4 percentage values (among leukocytes and lymphocytes); (ii) the increased sample throughput using CD45/CD4 staining; (iii) the extension of this protocol to include a second tube for CD45/CD8 staining in order to obtain CD4-plus-CD8 counts and CD4/CD8 ratios; and finally, (iv) the use of volumetric CD45 staining for generating absolute and differential counts for leukocyte subsets (20).

Our study reveals the practical advantages of volumetric two-color flow cytometry with CD45/CD4 and CD45/CD8 staining using generic MAbs. Volumetric cytometers, equipped with biosamplers of high capacity, Microsoft Windows-based autogating software, and reporting systems, efficiently handle 300 to 400 samples during a working day. As many as 15 parameters, including CD4 and CD8 analysis together with hematological leukocyte differentials, can be generated for cost-efficient monitoring of HIV-infected patients in large regional laboratories.

(Part of this research was presented at Monitoring and Diagnostic Tools for the Management of Antiretroviral Therapy in Resource-Poor Settings, a workshop held in Bethesda, Md., 11 to 13 November 2001, and arranged by Virology Education, B.V., Utrecht, The Netherlands.)

Top Abstract Introduction Materials and Methods Results Discussion References

 
Clinical samples. Samples (n = 93) were received for routine immunological diagnosis at an HIV-immunology laboratory and included patients at various stages of HIV infection (Table 1) as part of the routine diagnostic and quality assurance activity at the Royal Free Hospital. No extra specimens from HIV-seropositive patients were required. Twelve additional samples were taken from healthy volunteers 21 to 59 years of age as approved by the Institutional Ethics Committee (Table 1). These whole-blood samples were collected in EDTA and analyzed within 24 h using a "lyse-no-wash" procedure (15, 18). Briefly, in each tube, 10 or 20 µl of a diluted mixture of antibodies was admixed with 50 or 100 µl of whole blood, respectively. After 15 min of incubation at room temperature, 2.0 ml of lysing solution (0.17 M NH₄Cl) was added. The samples were counted after a final 15-min incubation (17, 24).

View this table: [in this window] [in a new window]

TABLE 1. Age, sex, and HIV status of patient population studieda

Instrumentation. Absolute lymphocyte subset counting was performed on three systems: (i) a CytoronAbsolute (Ortho Diagnostic Systems Inc., Raritan, N.J.) operating with Ortho Trio reagents and Immunocount II software to provide absolute counts by a volumetric method (10, 24); (ii) a FACSCalibur (Becton Dickinson Immunocytometry Systems, Oxford, United Kingdom) operating with TruCOUNT tubes (30) preloaded with a known number of beads (46,295 beads per tube); cell concentrations were calculated with the formula (number of events in the region containing the cell population/number of events in the region containing beads) x (46,295/test volume [i.e., 50 µl]); and (iii) a CytoronAbsolute system operating with Immunocount II software using panleucogating in order to record three parameters: side scatter (SSc), green fluorescence (CD45-fluorescein isothiocyanate [FITC]), and orange fluorescence (CD4-phycoerythrin [PE] or CD8-PE). The volumetric absolute counting properties of the Cytoron were utilized with both systems i and iii. (10, 24). The capacities of the automatic biosampler devices used were 100 (systems i and iii) and 40 (system ii) tubes. Total and differential white blood cell (WBC) counting was performed on a Bayer 120 hematology analyzer in the hospital's hematology laboratory as part of the routine service.

Reagents. During the volumetric-control procedure on the Ortho CytoronAbsolute, Ortho Trio MAbs were used (10, 24). These included three tubes comprising in tube 1 isotype controls (immunoglobulin G1 [IgG1] plus IgG2a-FITC-IgG1 plus IgG2a-PE-IgG2a-PECy5), in tube 2 CD4(OKT4)-FITC-CD8(OKT8)-PE-CD3(OKT3)-PECy5, and in tube 3 CD16(3G8)-FITC-CD19(OKB9)-PE-CD3(OKT3)-PECy5 (original clone designations are shown in italics). During the bead-based control procedure on the FACSCalibur, TruCOUNT tubes were used in combination with MultiTEST reagents (Becton Dickinson Immunocytometry Systems) to obtain absolute CD4 counts (30). These included CD3(SK7)-FITC-CD8(SK1)-PE-CD45(2D1)-PerCP-CD4(SK3)-APC. The new CD45-based protocol was also based on the volumetric procedure performed on the Ortho Cytoron. Two tubes containing two-color immunofluorescence (IF) reagents were each tested. Tube 1 contained CD45(2D1)-FITC-CD4(RFT4)-PE, and tube 2 comprised CD45(2D1)-FITC-CD8(RFT8)-PE. These generic reagents are available in unconjugated form from the National Institute for Biological Standards and Control (Potters Bar, United Kingdom).

Gating strategies for CD4 and CD8 enumeration. On the Ortho Cytoron, we employed the Trio reagents and obtained absolute counts for the following cell types: T cells (CD3⁺; low side scatter), CD4⁺ T lymphocytes (CD3⁺ CD4⁺ CD8^-), CD8⁺ T lymphocytes (CD3⁺ CD8⁺ CD4^-), B cells (CD19⁺; low side scatter), NK cells (CD3^- CD16⁺), and total lymphocytes (CD3⁺ T plus CD19⁺ B plus CD16⁺ NK cells referred to as Immunosum) (24). Percentage values for CD4⁺ T lymphocytes (CD4%) were derived as the number of CD4⁺ T cells divided by the total number of lymphocytes based on the criteria of CD4⁺, CD3⁺, and CD8^- cells/Immunosum (10, 18, 24). The CD4/CD8 ratios were calculated as (CD3⁺ CD4⁺)/(CD3⁺ CD8⁺) values. The internal quality control for pipetting errors was based on CD3 replicates using Immunocount II software (10): samples for which the CD3 replicates differed from the average absolute CD3 count by >5% were automatically flagged for further inspection. The event threshold was set to operate on forward scatter. On the FACSCalibur, the gating strategy recommended by the manufacturer was used, with the threshold set for red fluorescence (CD45) in a single tube (30).

For the new protocol, the gating strategy was based on CD45 panleucogating (13, 17, 19). A threshold was first set for green (CD45) fluorescence, and all WBCs were identified (Fig. 2) using a heterogeneous CD45/SSc dual-parameter histogram (CD45⁺ to CD45⁺⁺⁺ in gate A). All WBC events in gate A were then sent to a CD4/SSc histogram, where CD4 T cells were counted (CD4⁺⁺/SSc⁺ in gate E [Fig. 2]). The same gating strategy was applied for CD8 counting in a second tube. Here, only lymphoid cells with bright CD8 expression were counted as CD8 T cells (CD8⁺⁺/SSc⁺ in gate F (18). The CD4/CD8 ratios were calculated as (CD4⁺⁺ SSc⁺)/(CD8⁺⁺ SSc⁺) values. All these gating strategies were set to operate automatically and printed with all details (Fig. 2). The internal quality control for pipetting errors was based on CD45 WBC replicates using the Immunocount II program. If the CD45 total WBC replicates differed from the average absolute CD45 count by >5%, the samples were flagged. All flagged samples or those where the operator had detected gating irregularities were subsequently reanalyzed.

View larger version (44K): [in this window] [in a new window]

FIG. 2. CD45/CD4 double staining on blood using panleucogating with volumetric absolute counting. The graph report form is printed to document the autogating procedure. First, the CD45 side scatter histogram and gate A (all leukocytes) are established (left). All events of gate A are sent to the second display of CD4 side scatter (right). The CD4+ and lymphoid cells (in E) are automatically gated to provide the absolute CD4-T-cell count. E/A x 100 is the value of the CD4% among all leukocytes. The number of events in gate B (absolute lymphocyte count), gate C (absolute monocyte count), and gate D (absolute granulocyte count) are also defined. E/B x 100 is the CD4% value among lymphocytes. A parallel tube for CD45/CD8 double staining can also be run to provide the total of 15 parameters listed in Materials and Methods. QA, quality assurance; NEQAS, UK National External Quality Assessment Service.

In the second stage of the analysis, the different CD45 staining intensities among the leukocyte populations (20) were used to identify lymphocytes (CD45⁺⁺⁺/SSc⁺ in gate B), monocytes (CD45⁺⁺/SSc⁺⁺ in gate C), and granulocytes (CD45⁺/SSc⁺⁺⁺ in gate D). Using absolute counting and a two-color IF panel in two parallel tubes, the following 15 parameters were distinguished and stored: (i) total WBC counts, (ii) absolute CD4-T-cell counts, (iii) CD4-T-cell percentage among WBC, (iv) CD4-T-cell percentage among lymphocytes, (v) absolute CD8-T-cell counts, (vi) CD8-T-cell percentage among WBC, (vii) CD8-T-cell percentage among lymphocytes, (viii) absolute CD4- plus CD8-T-cell counts, (ix) CD4/CD8 ratio, (x) absolute lymphocyte counts, (xi) absolute monocyte counts, (xii) absolute granulocyte counts, (xiii) lymphocyte percentage among WBC, (xiv) monocyte percentage among WBC, and (xv) granulocyte percentage among WBC. In samples where a single tube was analyzed with CD45/CD4, 10 parameters (i to iv and x to xv) were recorded.

Data handling and statistical analysis. All results have been recorded in Microsoft Access-based spreadsheets. Following consultations with clinicians, forms were created for reports. Depending on the requests, these could include the single parameter of absolute CD4 count or all 10 to 15 parameters recorded above.

After we tested whether the differences between the methods were normally distributed (13), Bland-Altman plots (7) were used to investigate the agreement between the results obtained in two different systems, such as the panleucogating analysis on a volumetric flow cytometer versus a conventional "industry-standard" method. The standard techniques included the volumetric flow cytometer, CytoronAbsolute, using the full Trio panel, as well as the Becton Dickinson FACSCalibur running the TruCOUNT bead-based system. The absolute CD4⁺- and CD8⁺-lymphocyte counts and the percentages of these subsets among leukocytes and lymphocytes were studied. Bland-Altman (or bias) plots examine whether two methods have sufficient agreement to be used interchangeably. The average of values obtained by the two methods is plotted on the x axis, and the difference between the methods is plotted on the y axis. The average difference between the methods (bias), its 95% confidence intervals, and the limits of agreement (bias ± 2 standard deviations) are shown on the plots. The Pollock modification is identical to the Bland-Altman analysis (28) except that the percentage difference is expressed between the compared methods, which is best suited to illustrate a systematic bias across a wide range of absolute counts.

Top Abstract Introduction Materials and Methods Results Discussion References

 
CD4⁺-T-cell enumeration using primary CD45 and CD4 gating. Total lymphocytes were identified by volumetric counting (i) as the sum of T cells, B cells, and NK cells (Immunosum) using Trio MAbs (referred to as a full Trio panel) and (ii) as cells with a bright CD45 expression and lymphoid side scatter in the CD45-based protocol. No significant systematic bias was observed between the two methods (bias = -8 lymphocytes/mm³ [Fig. 3a ]).

View larger version (27K): [in this window] [in a new window]

FIG. 3. Bland-Altman plots to establish the agreements between the volumetric CD45/CD4 protocol, single tube, and the "state-of-the-art" single-platform technology. The parameters studied were the total absolute lymphocyte counts (a), CD4-T-cell percentage values among lymphocytes (b), and absolute CD4-T-cell counts (c and d). The standard technologies used were the full lymphocyte subset panel (three tubes) tested with the Ortho Trio panel on the CytoronAbsolute (a, b, and c) and the TruCOUNT bead-based method (one tube) performed on a FACSCalibur (d).

Next, CD4⁺-T-lymphocyte counts were determined by the full Trio panel and the CD45/CD4-based protocol, i.e., in the presence and absence of a CD3 reagent, respectively. The CD4% values among lymphocytes generated by the two methods showed a minimal bias of +0.38% (in favor of the Trio MAbs [Fig. 3b]). The absolute CD4-T-cell counts yielded by the two methods also showed excellent agreement (bias = +8 CD4⁺ cells/mm³; limits of agreement, between -29 and +46 CD4 cells/mm³ [Fig. 3c]).

The agreement between the volumetric absolute CD4-T-cell counts using CD45/CD4 gating and the bead-based TruCOUNT tube was also determined. An average bias of -10 CD4 cells/mm³ was observed with widened limits of agreement (-118 and +98 CD4 cells/mm³), similar to the values previously observed between the standard volumetric and bead-based single-platform technologies (13, 18).

Efficiency of the CD45/CD4 gating protocol on a volumetric system. After having documented CD4 enumeration using a CD45/CD4-based protocol by volumetric flow cytometer, we assessed the sample throughput of the system. A technician with a month of experience in flow cytometry processed 100 clinical samples using the autobiosampler. The steps of the procedure were monitored for time. A batch of 100 samples was processed in 95 min. The automated acquisition on the flow cytometer lasted for 120 min (Table 2), allowing the operator a 25-min break before starting to prepare the following batch. Three batches of 100 samples could be prepared within the normal 8-h working day. An additional batch was also prepared at the end of the day for unattended acquisition during the late hours, to be ready for inspection by the next morning. In total, 300 to 400 clinical samples could be processed each day.

View this table: [in this window] [in a new window]

TABLE 2. Timetable of routine operation using a biosampler with a 100-tube capacity

CD8⁺-T-cell enumeration using primary CD45 and CD8 gating. We next evaluated the agreement for CD8 enumeration between the CD45-based protocol and the full Trio panel. With the latter protocol, similar to the other currently recommended protocols, CD8⁺ T cells are counted when they coexpress both CD3 and CD8 molecules. Using the CD45-based protocol in the absence of a CD3 reagent, a tight gate was placed around lymphoid cells with bright CD8 expression (median, 130 x 10³ antibody binding capacity per cell), excluding most NK cells (range, 10 x 10³ to 110 x 10³ antibody binding capacity per cell; median, 24 x 10³ ABC per cell) from the CD8 gate. The correlation was excellent throughout the whole CD8 range (Fig. 4a), but a systematic bias was observed (+40 CD8 T cells/mm³; 95% confidence interval, +32 to +48) (Fig. 4b), representing +5.2% of CD8⁺ lymphocytes (Fig. 4c).

View larger version (29K): [in this window] [in a new window]

FIG. 4. Evaluation of the agreement between the volumetric absolute CD8-T-cell counts generated with the CD45/CD8 protocol (CD8++ SSc+) and the full Trio panel (CD3+ CD8+). The results using linear regression (a) and the Bland-Altman plot (b) and its Pollock modification (c) are shown. In the Pollock modification, the differences between the two methods of counting CD8 T cells were expressed as a percentage of the total CD8 counts to illustrate the systematic bias at a 5% level.

The CD4/CD8 ratios were also evaluated in samples by the volumetric method, using the CD45/CD4 and CD45/CD8 protocols in two parallel tubes, and compared to the CD4/CD8 ratios observed with the full Trio panel (Fig. 5a). The agreements were good with virtually no bias (-0.05 CD4/CD8; limits of agreement, between -0.21 and +0.12 CD4/CD8) (Fig. 5a).

View larger version (32K): [in this window] [in a new window]

FIG. 5. Bland-Altman plots (a and b) and the Pollock modification (c) to establish agreements on the Cytoron between the volumetric CD45/CD4-plus-CD45/CD8 two-tube protocol and the standard volumetric method using Trio reagents. The parameters studied were the CD4/CD8 ratios (a) and the sum of the absolute CD4- plus CD8-T-cell counts versus the CD3+-T-cell counts (b and c, respectively). In the Pollock modification (c), the differences in total T-cell counts were expressed as percentages of T-cell counts to illustrate the regular underestimation of total CD3+-T-cell counts, at a 10% level, by the CD45 protocol. This bias is due to the existence of CD3+ CD4- CD8- T lymphoid cells.

We extended our study to investigate the agreement between the sum of the CD4⁺ and CD8⁺ T cells generated with the volumetric CD45 protocol and the T cells observed using CD3 staining in the full Trio protocol. The CD45-based protocol failed to identify CD3⁺ lymphoid cells doubly negative for CD4 and CD8 antigens (CD3⁺ CD4^- CD8^-). There was a bias of +125 T cells/mm³ (Fig. 5b) in favor of the CD3⁺-T-cell counts recorded on the full Trio panel. These CD3⁺ CD4^- CD8^- T cells represented a 10.1% bias throughout the whole range of the T-cell counts (Fig. 5c).

WBC subset enumeration using CD45-based protocols on a volumetric flow cytometer. The expression of CD45 antigen is the common feature of all WBCs, and the CD45 staining intensity plus SSc distinguishes lymphocytes, monocytes, and granulocytes (Fig. 2) (20). We investigated the agreement between counts generated by this method and those yielded by a hematology analyzer in the routine hematology laboratory of our institution. The agreements for total WBCs, lymphocytes, and granulocytes were good, with a minimal bias of -136 WBCs/mm³, -70 lymphocytes/mm³, and +78 granulocytes/mm³ (Table 2). However, the agreement for monocyte enumeration was poor. The hematology analyzer underestimated the monocyte counts with a bias of -179 monocytes/mm³. This is a large value, representing 35 to 40% of the total monocyte counts, as already reported for several hematology analyzers (14, 19).

Top Abstract Introduction Materials and Methods Results Discussion References

 
The need to improve laboratory services for regions of the world where the HIV epidemic threatens to destroy the fabric of life has revitalized efforts to identify the most efficient techniques for monitoring HIV disease. The present changes relate to the common areas of routine immunology and hematology, such as quality assurance, sample processing, and transportation, as well as to the challenges of how to optimally count blood cells (Fig. 1). Immunological methods, based on the specificities and discriminating capacities of MAbs, have recently made an impact by recognizing even minor subsets of functionally divergent blood cells (9, 24, 26, 29, 30). By using flow cytometry, the true power of directly identifying cells by antibodies, as opposed to first investigating merely their morphological features, is now documented, and the strategy of primary immunological gating is widely used (12, 18, 20, 22). The relevant examples include CD45 for leukocytes and their subpopulations (4, 13, 20), CD3 for T cells (22, 25), CD4 for the major T-cell subset and monocytes (17, 18), and CD8 for the minor T-cell subset and some NK cells (18). Reliable total lymphocyte counts have been achieved by the Immunosum technique (24), providing the sum of the immunogated CD3⁺ (T), CD19⁺ (B), and CD16⁺ (NK) cells instead of using only the lymphocytic scatter appearance. The commonly used display on the cytometers is referred to as a heterogeneous, or morphospectral, protocol (23, 27) to show the IF of cells stained with MAb (on one axis) and the side scatter profile of cells (on the other axis) (Fig. 2).

In our study, we combined immunological CD45 gating with volumetric absolute counting on single platforms in order to introduce a robust method for WBC counting and for enumerating CD4⁺ and CD8⁺ T cells. Our four main findings are as follows.

First, this study confirms our previous work, also performed on volumetric flow cytometers (18), as to the good agreement between the absolute CD4⁺-T-cells counts obtained by direct CD4 gating and by CD4⁺ CD3⁺ coexpression (Fig. 3c). Importantly, however, when we previously used CD4 MAb on its own without CD45, reliable CD4%-per-lymphocyte values could be obtained only with the constant vigilance of an experienced operator, who frequently had to manually modify the lymphocyte gates, a time-wasting procedure (18). We have now added CD45 gating to the protocol and report the excellent agreement between lymphocyte counts determined by CD45-side scatter and by the Immunosum method using the full Trio panel (Fig. 3a). Thus, CD45 staining improves the efficiency of the new autogated protocol (Fig. 2), saving effort and technicians' time. Similarly, this gating strategy shows no bias compared to the bead-based CD4 counts (30) but reveals occasional differences leading to a wider spread (Fig. 3d). This discrepancy might be a bead-related phenomenon, because similar results are seen when CD4 counts obtained by panleucogating on a double platform are compared to counts obtained by the bead-based method (13, 18).

The second conclusion is that the CD45/CD4 protocol on a volumetric cytometer provides an efficient system in which a trained flow cytometrist can run large numbers of tubes per day (>300 samples using CD45/CD4 alone [Table 2]). If two parallel tubes are used with CD45/CD4- and CD45/CD8-double-stained cells, >150 blood samples can be studied. Obviously, such intensive diagnostic activity needs to be supplemented by clerical help and supervisory capacity. Nevertheless, this capacity illustrates the high efficiency of flow cytometry compared to that of manual methods such as the Dynabeads system (11), where a single assistant can manually handle only 15 to 20 samples per day. A hugely increased workload for CD4-T-cell enumeration is in line with the expected demand generated by the arrival of generic drugs for antiretroviral therapy. The larger regional centers dedicated to nationwide support with organized sample transportation using TransFix blood stabilizers (17) will require this increased service capacity.

The technical efficiency of this technology is directly related to three factors: (i) the fluent operation with a robust autogating process, where only <2 to 4% of samples need attention for regating (see above) (Fig. 2), (ii) the use of an efficient autobiosampler (10, 24), and (iii) a convenient system using a Windows environment and a Microsoft Access database for feedback to the clinicians. Flexible reporting, based on consultation with clinicians, may include only CD4 counts or any of the 15 parameters listed in Materials and Methods.

The third finding of our study is related to the use of CD3, the specific T-cell marker. Arguably, CD3 is not required to identify CD4⁺ T cells (13, 17, 18). However, the CD8⁺-lymphocyte populations are more complex (18) and display CD8 antigen over a wide range (15 x 10³ to 140 x 10³ CD8 molecules/cell [5]). The CD8⁺ cells include 80 to 92% proper CD8⁺ CD3⁺ T cells that display CD8 at a high level (CD8⁺⁺; 80 x 10³ to 140 x 10³/cell) and 8 to 20% CD8⁺ CD3^- NK cells that express CD8 at a lower level (CD8⁺; <80 x 10³/cell). It is therefore logical to place a tight gate around the CD8⁺⁺ population and compare these results with those obtained by counting CD3⁺-gated CD8 T cells (18). The results described above show that the CD8⁺⁺ gate underestimates CD3⁺ CD8⁺ counts by 5.2% (Fig. 4c). This bias is apparently too modest to influence the CD4/CD8 ratios (bias, -0.05 [Fig. 5a]). An extra advantage of running both CD45/CD4 and CD45/CD8 tubes is the availability of CD4- plus CD8-T-cell counts that disregard the CD3⁺ CD4^- CD8^- T cells. We have argued elsewhere that these double-negative T cells represent a functionally different, mostly T-cell receptor ß-negative subset that should not be included in the total T-cell counts (18).

Finally, Loken et al. (20) have documented the differential expression of CD45 antigen on lymphocytes, granulocytes, and CD14⁺ monocytes. In our study, the CD45 analysis is combined with volumetric counting in order to generate absolute leukocyte differential counts. These parameters, when defined on hematological counters, can be error prone (3, 19, 33), and the monocyte counts are frequently underestimated (Table 3) (14, 19). On the other hand, the monocyte counts obtained by CD45 gating and carefully confirmed by the CD14 monocytic marker expression (20) are more accurate. Consequently, the methods described above, in combination with the use of stabilized blood preparations with long shelf lives (1, 13), will assist the establishment of long-awaited quality assurance schemes for leukocyte differentials and absolute counts, which are required to coordinate the performance of the wide variety of different hematology analyzers.

View this table: [in this window] [in a new window]

TABLE 3. Comparative performances of a hematology analyzer (Bayer 120) and the simplified CD45-based protocol on the CytoronAbsolute for absolute WBC enumeration

In conclusion, the present volumetric CD45/CD4 flow cytometry, assisted by more affordable sources of MAbs, has wide applicability in the routine laboratories operating in economy-conscious environments. The specification required for the two-color IF plus side scatter used in this study is within the reach of the newly designed, battery-operated, smaller-volumetric-flow cytometers that carry red diodes or other small light sources as the sole source of light excitation (19, 31) and are also capable of performing bead-based enzyme-linked immunosorbent assays with the multiplexing technology (19) in the area of the differential diagnosis of infectious diseases (16).

 
I.V.J. is an AVERT Ph.D. scholar on a grant provided to G.J. and a receiver of an ORS award from United Kingdom Universities. This study was supported by grants to G.J. (Concerted Action Contract BMH4-97-2611 of the Biomed-2 program and grant QLRI-2000-00436 "Quality of Life and Management of Living Resources") from the European Commission, Brussels, Belgium, and to D.K.G. (Bristol-Myers Squibb "Secure the Future").

We are grateful for the generosity of the Royal Free Medical School and the Imperial Cancer Research Fund for the deposition of the RFT4 (CD4), RFT8 (CD8), and 2D1 (CD45) clones at the National Institute for Biological Standards and Control and at the Witwatersrand University, Johannesburg, South Africa, for potential general use.

 
* Corresponding author. Mailing address: HIV Immunology, Department of Immunology and Molecular Pathology, Royal Free and University College Medical School, Rowland Hill St., London NW3 2PF, United Kingdom. Phone: 44-20-7830 2349. Fax: 44-20-7431 0879. E-mail: janossy{at}rfhsm.u-net.com.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Barnett, D., V. Granger, P. Mayr, I. Storie, G. A. Wilson, and J. T. Reilly. 1996. Evaluation of a novel stable whole blood quality control material for lymphocyte subset analysis: results from the UK NEQAS immune monitoring scheme. Cytometry 26:216-222.[CrossRef][Medline]
2
2. Barnett, D., V. Granger, A. G. Pockley, J. M. Saxton, L. Storie, L. Whitby, and J. T. Reilly. 1998. TransFix: a sample stabilising fluid for use in cellular haematology and immunology. Cytometry 38:88.
3
3. Bentley, S. A., A. Johnson, and C. A. Bishop. 1993. A parallel evaluation of four automated hematology analyzers. Am. J. Clin. Pathol. 100:626-632.[Medline]
4
4. Bergeron, M., J. K. Nicholson, S. Phaneuf, T. Ding, N. Soucy, A. D. Badley, N. C. Hawley Foss, and F. Mandy. 2002. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry 50:53-61.[CrossRef][Medline]
5
5. Bikoue, A., F. George, P. Poncelet, M. Mutin, G. Janossy, and J. Sampol. 1996. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 26:137-147.[CrossRef][Medline]
6
6. Bikoue, A., G. Janossy, and D. Barnett. 2002. Stabilised cellular immmuno-fluorescence assay (SCIFA): CD45 expression as a calibration standard for human leukocytes. J. Immunol. Methods 266:19-32.
7
7. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet i:307-310.
8
8. Bofill, M., G. Janossy, C. A. Lee, D. MacDonald-Burns, A. N. Phillips, C. Sabin, A. Timms, M. A. Johnson, and P. B. Kernoff. 1992. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin. Exp. Immunol. 88:243-252.[Medline]
9
9. Brando, B., D. Barnett, G. Janossy, F. Mandy, B. Autran, G. Rothe, B. Scarpati, G. D'Avanzo, J. L. D'Hautcourt, R. Lenkei, G. Schmitz, A. Kunkl, R. Chianese, S. Papa, J. W. Gratama, et al. 2000. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 42:327-346.[CrossRef][Medline]
10
10. Connelly, M. C., M. Knight, J. V. Giorgi, J. Kagan, A. L. Landay, J. W. Parker, E. Page, C. Spino, C. Wilkening, and T. J. Mercolino. 1995. Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors. Cytometry 22:200-210.[CrossRef][Medline]
11
11. Didier, J. M., M. D. Kazatchkine, C. Demouchy, C. Moat, S. Diagbouga, C. Sepulveda, A. M. Di Lonardo, and L. Weiss. 2001. Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries. J. Acquir. Immune Defic. Syndr. 26:193-195.
12
12. Gelman, R., and C. Wilkening. 2000. Analyses of quality assessment studies using CD45 for gating lymphocytes for CD3(+)4(+)%. Cytometry 42:1-4.[CrossRef][Medline]
13
13. Glencross, D. K., L. E. Scott, I. V. Jani, D. Barnett, and G. Janossy. 2002. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50:69-77.[CrossRef][Medline]
14
14. Goossens, W., L. Van Hove, and R. L. Verwilghen. 1991. Monocyte counting: discrepancies in results obtained with different automated instruments. J. Clin. Pathol. 44:224-227.[Abstract/Free Full Text]
15
15. Hoffman, R. A., P. C. Kung, W. P. Hansen, and G. Goldstein. 1980. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc. Natl. Acad. Sci. USA 77:4914-4917.[Abstract/Free Full Text]
16
16. Jani, I. V., G. Janossy, D. W. G. Brown, and F. Mandy. 2002. Multiplex immunoassays by flow cytometry for diagnosis and surveillance of infectious diseases in resource-poor settings. Lancet Infect. Dis. 2:243-250.[CrossRef][Medline]
17
17. Jani, I. V., G. Janossy, A. Iqbal, F. S. Mhalu, E. F. Lyamuya, G. Biberfeld, D. K. Glencross, L. Scott, J. T. Reilly, V. Granger, and D. Barnett. 2001. Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J. Immunol. Methods 257:145-154.[CrossRef][Medline]
18
18. Janossy, G., I. V. Jani, and W. Gohde. 2000. Affordable CD4(+) T-cell counts on ‘single-platform’ flow cytometers. I. Primary CD4 gating. Br. J. Haematol. 111:1198-1208.[CrossRef][Medline]
19
19. Janossy, G., I. V. Jani, M. Kahan, D. Barnett, F. Mandy, and H. Shapiro. 2002. Precise CD4 T cell counting using red diode laser excitation: for richer, for poorer. Cytometry 50:78-85.[CrossRef][Medline]
20
20. Loken, M. R., J. M. Brosnan, B. A. Bach, and K. A. Ault. 1990. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453-459.[CrossRef][Medline]
21
21. Mandy, F., M. Bergeron, G. Houle, J. Bradley, and J. Fahey. 2002. Impact of the international program for quality assessment and standardization for immunological measures relevant to HIV/AIDS: QASI. Cytometry 50:111-116.[CrossRef][Medline]
22
22. Mandy, F., M. Bergeron, D. Recktenwald, and C. A. Izaguirre. 1992. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. Comparison with conventional two-color immunophenotyping method. J. Immunol. Methods 156:151-162.[CrossRef][Medline]
23
23. Mandy, F., J. K. Nicholson, B. Autran, and G. Janossy. 2002. T-cell subset counting and the fight against AIDS: reflections over a 20-year struggle. Cytometry 50:39-45.[CrossRef][Medline]
24
24. Mercolino, T. J., M. C. Connelly, E. J. Meyer, M. D. Knight, J. W. Parker, G. T. Stelzer, and G. DeChirico. 1995. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 22:48-59.[CrossRef][Medline]
25
25. Nicholson, J. K., M. Hubbard, and B. M. Jones. 1996. Use of CD45 fluorescence and side scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 26:16-21.[CrossRef][Medline]
26
26. O'Gorman, M. R. G., R. Gelman, Site Investigators, and the NIAID New CD4 Technologies Focus Group. 1997. Inter- and intrainstitutional evaluation of automated volumetric capillary cytometry for the quantitation of CD4- and CD8-positive T lymphocytes in the peripheral blood of persons infected with human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 4:173-179.[Abstract]
27
27. O'Gorman, M. R., and J. K. Nicholson. 2000. Adoption of single-platform technologies for enumeration of absolute T-lymphocyte subsets in peripheral blood. Clin. Diagn. Lab. Immunol. 7:333-335.[Free Full Text]
28
28. Pollock, M. A., S. G. Jefferson, J. W. Kane, K. Lomax, G. MacKinnon, and C. B. Winnard. 1992. Method comparison—a different approach. Ann. Clin. Biochem. 29:556-560.
29
29. Reimann, K. A., M. R. G. O'Gorman, J. Spritzler, C. L. Wilkening, D. E. Sabath, K. Helm, D. E. Campbell, and The NIAID DAIDS New Technologies Evaluation Group. 2000. Multisite comparison of CD4 and CD8 T-lymphocyte counting by single- versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. Clin. Diagn. Lab. Immunol. 7:344-351.[Abstract/Free Full Text]
30
30. Schnizlein-Bick, C. T., J. Spritzler, C. L. Wilkening, J. K. A. Nicholson, M. R. G. O'Gorman, Site Investigators, and The NIAID DAIDS New Technologies Evaluation Group. 2000. Evaluation of TruCount absolute-count tubes for determining CD4 and CD8 cell numbers in human immunodeficiency virus-positive adults. Clin. Diagn. Lab. Immunol. 7:336-343.[Abstract/Free Full Text]
31
31. Shapiro, H. M. 1995. Practical flow cytometry, 3rd ed. Wiley-Liss, Inc., New York, N.Y.
32
32. Sherman, G. G., J. S. Galpin, J. M. Patel, B. V. Mendelow, and D. K. Glencross. 1999. CD4+ T cell enumeration in HIV infection with limited resources. J. Immunol. Methods 222:209-217.[CrossRef][Medline]
33
33. Simson, E., and W. Groner. 1995. Variability in absolute lymphocyte counts obtained by automated cell counters. Cytometry 22:26-34.[CrossRef][Medline]

---

Clinical and Diagnostic Laboratory Immunology, September 2002, p. 1085-1094, Vol. 9, No. 5
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.5.1085-1094.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Pattanapanyasat, K., Lerdwana, S., Noulsri, E., Chaowanachan, T., Wasinrapee, P., Sakulploy, N., Pobkeeree, V., Suksripanich, O., Thanprasertsuk, S., Spira, T. J., Tappero, J. W., Levine, W. C. (2005). Evaluation of a New Single-Parameter Volumetric Flow Cytometer (CyFlowgreen) for Enumeration of Absolute CD4+ T Lymphocytes in Human Immunodeficiency Virus Type 1-Infected Thai Patients. CVI 12: 1416-1424 [Abstract] [Full Text]  
• Imade, G. E., Badung, B., Pam, S., Agbaji, O., Egah, D., Sagay, A. S., Sankale, J.-L., Kapiga, S., Idoko, J., Kanki, P. (2005). Comparison of a New, Affordable Flow Cytometric Method and the Manual Magnetic Bead Technique for CD4 T-Lymphocyte Counting in a Northern Nigerian Setting. CVI 12: 224-227 [Abstract] [Full Text]  
• Bussmann, H., Wester, C. W., Masupu, K. V., Peter, T., Gaolekwe, S. M., Kim, S., Reich, A. M., Ahn, S., Wu, Y., Thior, I., Essex, M., Marlink, R. (2004). Low CD4+ T-Lymphocyte Values in Human Immunodeficiency Virus-Negative Adults in Botswana. CVI 11: 930-935 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Janossy, G. Articles by Glencross, D. K. Search for Related Content PubMed PubMed Citation Articles by Janossy, G. Articles by Glencross, D. K.